Tech Company Financing Transactions
NovoStent Funding Round
NovoStent, based in Mountain View, scored $1.1 million from Montreux Equity Partners and Sanderling Ventures.
Transaction Overview
Company Name
Announced On
6/30/2009
Transaction Type
Venture Equity
Amount
$1,056,000
Round
Undisclosed
Investors
Montreux Equity Partners (Howard Palefsky)
Sanderling Ventures (Timothy Mills)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Medical Devices & Instruments
Mailing Address
1400 Terra Bella Ave E
Mountain View, CA 94043
USA
Mountain View, CA 94043
USA
Phone
Website
Email Address
Overview
NovoStent Corporation is a medical device company that has developed a novel anchored helical stent technology to provide a wide range of vascular therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rick Randall
Browse more venture capital transactions:
Prev: 6/30/2009: Mixx venture capital transaction
Next: 6/30/2009: LifeLock venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs